1-3 of 3
Claritsa Santos-Malave
Close
Sort by
Journal Articles

Results of a Phase I/II Study of the Combination of 5-aza-2′-Deoxycytidine (DAC) and Valproic Acid (VPA) in Patients (pts) with Leukemia.

Guillermo Garcia-Manero, MD, Hagop Kantarjian, MD, Blanca Sanchez-Gonzalez, MD, Stefan Faderl, MD, Srdan Verstovsek, MD, Farhad Ravandi, MD, Michael Ryttling, MD, Jorge Cortes, MD, William Wierda, MD, Koyu Hoshino, MD, Hui Yang, MD, Claritsa Santos-Malave, Jackie Fiorentino, RN, Elias Jabbour, MD, Gary Rosner, PhD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2004) 104 (11): 263.
https://doi.org/10.1182/blood.V104.11.263.263
Published: 2004
Journal Articles

In Vitro Effects of the Combination of Idarubicin (IDA) with Suberoylanilide Hydroxamic Acid (SAHA) or Valproic Acid (VPA) in Leukemia Cell Lines.

Blanca Sanchez-Gonzalez, M.D., Koyu Hoshino, M.D., Carlos Bueso-Ramos, M.D., Hui Yang, M.D., Emile Youssef, M.D., Ph.D., Yanis Boumber, M.D., Claritsa Santos-Malave, Guillermo Garci-Manero, M.D.
Journal: Blood
Blood (2004) 104 (11): 1173.
https://doi.org/10.1182/blood.V104.11.1173.1173
Published: 2004
Journal Articles

Aberrant DNA Methylation of the Src Tyrosine Kinase Hck Is a Frequent Event in Human Leukemia and May Predict for Poor Prognosis in Adult Acute Lymphocytic Leukemia (ALL).

Koyu Hoshino, MD, Hui Yang, MD, Claritsa Santos-Malave, Blanca Sanchez-Gonzalez, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2004) 104 (11): 1542.
https://doi.org/10.1182/blood.V104.11.1542.1542
Published: 2004